Zolgensma 2 x 1013 vg (vector genomes)/mL solution for infusion ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
3	脊髄性筋萎縮症	1

3. 脊髄性筋萎縮症

臨床試験数 : 237 / 薬物数 : 123 - (DrugBank : 29) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 75

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-006781-21-DK (EUCTR)		20/12/2022	Long-term follow-up of patients with spinal muscular atrophy Treated with OAV101 in Clinical Trials	Long-term follow-up of patients with spinal muscular atrophy Treated with OAV101 IT or OAV101 IV in ...	Spinal Muscular Atrophy MedDRA version: 20.1;Level: PT;Classification code 10041582;Term: Spinal mus ...	Trade Name: Zolgensma 2 x 1013 vg (vector genomes)/mL solution for infusion Product Name: OAV101 Produ ...	Novartis Pharma AG	NULL	NA			Female: yes Male: yes	260	Phase 4	United States;Saudi Arabia;Taiwan;Greece;Thailand;Spain;Colombia;Switzerland;Italy;India;France;Mala ...

First Previous1Next Last